Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2003
11/04/2003US6642223 Benzoheterocyclic derivatives
11/04/2003US6642215 Using cyanoguanidine compound; anticancer agents
11/04/2003CA2290709C 2,6-diaminopyridine compounds as intermediates for producing antibacterial dihydropyridone carboxylic acid derivatives
11/04/2003CA2266006C Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
11/04/2003CA2232728C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
11/04/2003CA2078517C Process for the preparation of omeprazole
10/2003
10/30/2003WO2003089427A1 Indol-2-ones as selective inhibitors of cyclooxygenase-2
10/30/2003WO2003089426A1 Medicine for prevention and/or therapy of disseminated intravascular coagulation syndrome
10/30/2003WO2003089425A1 Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-$g(a), $g(a)-dimethyl-benzeneacetic
10/30/2003WO2003089412A1 Antibacterial agents
10/30/2003WO2003089409A1 Compounds having affinity at 5ht2c receptor and use thereof in therapy
10/30/2003WO2003089408A2 Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts
10/30/2003WO2003089383A1 Non-heating clay composites for building materials
10/30/2003WO2003088967A1 (1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
10/30/2003WO2003088963A1 5-oxo and 5-thio derivatives of 5h-indeno'1,2-bipyridine with adenosine a2a receptor binding and phosphodiesterase inhibiting activity for the treatment of neurodegenerative disorders and inflammation related diseases
10/30/2003WO2003088961A1 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
10/30/2003WO2003088917A2 Regulation of tnf-alpha
10/30/2003WO2003088908A2 Heterocyclo inhibitors of potassium channel function
10/30/2003WO2003088900A2 Solid forms of salts with tyrosine kinase activity
10/30/2003WO2003066629A3 Heteroaryl compounds useful as inhibitors of gsk-3
10/30/2003WO2003066579A3 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
10/30/2003WO2003053330A3 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer’s disease and conditions associated with glycogen synthase kinase-3
10/30/2003WO2003051833A3 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
10/30/2003WO2003051277A3 Novel compounds
10/30/2003WO2003051275A3 Benzodiazepine derivatives, preparation thereof and use thereof
10/30/2003WO2003051274A3 Benzodiazepine derivatives, preparation thereof and use thereof
10/30/2003WO2003037274A3 Pyrazole-amides and-sulfonamides
10/30/2003WO2003026415A3 Insecticidal diamides
10/30/2003WO2003015608A3 Combination therapy for the treatment of cancer
10/30/2003WO2002072571A3 Pyridinyl pyrazoles useful for the treatment of copd
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003US20030204090 Administering to a patient an indazoline compound to treat cancer, inflammatory disorder or autoimmune disease
10/30/2003US20030204086 Novel heterocyclic amide derivatives
10/30/2003US20030203954 Substituted 3, 5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
10/30/2003US20030203926 For treatment of inflammatory or autoimmune condition, viral infection, cancer
10/30/2003US20030203922 Substituted amine derivatives and methods of use
10/30/2003US20030203920 Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
10/30/2003US20030203917 Compounds and methods for the treatment of neoplastic disease
10/30/2003US20030203914 Implicated as playing a key role in processes involving cellular invasion and tissue remodelling including wound repair, bone remodelling, angiogenesis, tumour invasiveness and spread of metastases
10/30/2003US20030203913 Beta3 adrenergic receptor agonists and uses thereof
10/30/2003US20030203910 A phenoxy-alkyl-quinoxalinone derivatives for inhibiting drug transport proteins that efflux therapeutic agents from cells; synergistic
10/30/2003US20030203907 Novel pyrazinone derivatives
10/30/2003US20030203905 Inhibitors of p38
10/30/2003US20030203904 Antitumor agents for treating cancer
10/30/2003US20030203890 Administering a neurotrophic compound 2-pyrrolidinecarboxylate derivatives after prostate surgery as well as erectile dysfunction
10/30/2003US20030203889 Phenylsulphonyl derivatives as 5-HT receptor ligands
10/30/2003US20030203877 Such as dipyroxylamine; for treating and preventing chronic tissue damage and diabetic complications (dialysis-related pathologies, proteinuria, impaired glomerular clearance, diabetic nephropathy, and protein crosslinking)
10/30/2003EP1496982A2 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2488929A1 5-oxo and 5-thio derivatives of 5h-indeno'1,2-bipyridine with adenosine a2a receptor binding and phosphodiesterase inhibiting activity for the treatment of neurodegenerative disorders and inflammation related diseases
10/30/2003CA2484017A1 Indol-2-ones as selective inhibitors of cyclooxygenase-2
10/30/2003CA2481940A1 (1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
10/30/2003CA2480325A1 Solid forms of salts with tyrosine kinase activity
10/29/2003EP1357121A1 Azaring-ether deritatives and their use as nicotinic ach receptor modulators
10/29/2003EP1357120A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
10/29/2003EP1357111A1 Pyridone derivative having affinity for cannabinoid 2-type receptor
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355904A2 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/29/2003EP1355903A1 Pyrazole derivatives against tgf overexpression
10/29/2003EP1355902A1 Sulfonamide compounds, their preparation and use
10/29/2003EP1355901A2 1,1-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLOPROTEASE AND TNF-$g(a)
10/29/2003EP1355900A2 Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands
10/29/2003EP1355899A1 Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
10/29/2003EP1355889A1 Substituted triazole diamine derivatives as kinase inhibitors
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1355886A1 Fused heterocyclic compounds
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355878A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/29/2003EP1355648A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a)
10/29/2003EP1153920B1 Quinoline derivatives and quinazoline derivatives
10/29/2003EP1149092B1 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
10/29/2003EP1147112B1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
10/29/2003EP1112256B1 Cyclohexenonquinolinoyl-derivatives as herbicidal agents
10/29/2003EP1012166B1 1-amino-7-isoquinoline derivatives as serine protease inhibitors
10/29/2003EP0843663B9 4-aryl-thio-pyridin-2(1h)-ones, drugs containing same, and uses thereof for treating hiv-related diseases
10/29/2003EP0633881B1 Amine derivatives of oxo- and hydroxy-substitued hydrocarbons
10/29/2003CN1452620A Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation
10/29/2003CN1452619A Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
10/29/2003CN1452488A Treatment of inflammatory disorders
10/28/2003US6639076 Such as 2-(2-amino-2-methylpropanoylamino)-n-(1-(2-oxo-1-phenyl-2-pyrrolidinylethyl -4-yl)-4-phenylbutanamide
10/28/2003US6638980 Inhibitors of factor Xa
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/28/2003US6638965 Antitumor agents
10/28/2003US6638964 Sulfonamide-containing indole compounds
10/28/2003US6638962 Cycloheptene compounds
10/28/2003US6638956 Pesticidal 1-arylpyrazoles
10/28/2003US6638954 Δ2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke
10/28/2003US6638953 Indole derivatives as 5-HT receptor antagonist
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638948 A free-flowing, amorphous paroxetine hydrochloride composition suitable as a therapeutic agent for premature ejaculation can be prepared by dissolving paroxetine free base in a hydrochloric acid-ethanol solution followed by
10/28/2003US6638945 Quinoline derivatives as inhibitors of MEK enzymes
10/28/2003US6638944 Have urea containing substituent at 1-position; induce biosynthesis of cytokines such as interferon and tumor necrosis factor, exhibit antiviral and antitumor properties
10/28/2003US6638942 Spiro-indolines as Y5 receptor antagonists
10/28/2003US6638940 Tetrahydropyridines as pesticides
10/28/2003US6638939 6,7-dimethoxyquinazolines and therapeutic use thereof
10/28/2003US6638937 As antihypertensive agents; for therapy of disorders related to renal, glomerular and mesangial cell function; therapy of endotoxemia or endotoxin shock as well as hemorrhagic shock; useful in alleviation of pain associated cancer
10/28/2003US6638929 Tricyclic protein kinase inhibitors
10/28/2003US6638927 Melanocortin-4 receptor (MC4-R) agonists; treating obesity or diabetes; 4-((N-cyclohexyl-3,5-dimethyl-piperazine-1-carboximidoyl)-amino)-N-(2-(2,4 -dichlorophenyl) -ethyl)-benzamide for example
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003CA2254521C New pyrrol derivatives, their method of preparation and pharmaceutical compositions containing these derivatives
1 ... 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 ... 1080